Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease.
Brauner S, Zhou W, Backlin C, Green TM, Folkersen L, Ivanchenko M, Löfström B, Xu-Monette ZY, Young KH, Møller Pedersen L, Boe Møller M, Sundström C, Enblad G, Baecklund E, Wahren-Herlenius M.
Brauner S, et al. Among authors: sundstrom c.
J Intern Med. 2015 Sep;278(3):323-32. doi: 10.1111/joim.12375. Epub 2015 May 29.
J Intern Med. 2015.
PMID: 25880119
Free article.